Tricase

Italy

83 total trials 46 recruiting

Filter these 83 trials by phase, condition, sponsor and more.

Open in Search →

A Combination of Acalabrutinib with R-CHOP in Subjects with previously untreated non-GCB DLBCL Ended recruitment

2023-509358-72-00 5 2020-11-23 Diffuse large B-cell lymphoma
A Phase 3 clinical study to investigate the effects of BAN2401 in patients with Early Alzheimer's Disease. Ended recruitment

2024-510887-22-00 5 2019-09-30 Mild cognitive impairment due to Alzheimer's disease or mild Alzheimer
Phase II multicenter single arm study to evaluate the efficacy and safety of ibrutinib in combination to rituximab-CHOP followed by ibrutini … Ended recruitment

2024-511641-18-00 4 2019-08-01 Diffuse Large B-cell Lymphoma ABC
REVOLUTION - Randomized phasE 2 study of Valproic acid in combination with bevacizumab and Oxaliplatin/fLUoropyrimidine regimens in patients … Ended recruitment

2024-516844-25-01 4 2019-01-03 Patients with ras-mutated metastatIc colorectal cancer
Use of circulating tumor dna test to intensify post-operative treatment of patients with resected colon cancer. Halted

2024-515152-20-00 4 2023-03-02 Stage III and high-risk stage II resected colon cancer patients.
Study Comparing Bemarituzumab plus Chemotherapy with Placebo and Chemotherapy in Previously Untreated Advanced Gastric or Gastroesophageal J … Ended

2023-505457-40-00 5 2022-02-02 Previously Untreated Advanced Gastric or Gastroesophageal Junction Can
A study to investigate the safety and efficacy of AMX0035 in patients with Amyotrophic Lateral Sclerosis Ended

2023-508511-23-00 5 2021-12-02 Amyotrophic Lateral Sclerosis (ALS)
The BURAN Study of Buparlisib (AN2025) In Combination with Paclitaxel Compared to Paclitaxel Alone, in Patients with Recurrent or Metastatic … Ended

2024-517251-12-00 5 2021-11-02 Recurrent or metastatic head and neck squamous cell carcinoma
A Phase 3 Study to Evaluate Efficacy and Safety of AL001 in Frontotemporal Dementia (INFRONT-3) Ended

2023-506873-36-00 5 2020-06-29 Frontotemporal dementia (FTD)
Rituximab, bendamustine and cytarabine followed by venetoclax (V-RBAC) in high-risk elderly patients with mantle cell lymphoma (MCL) Ended

2024-511533-35-00 4 2018-09-03 Mantle Cell Lymphoma
autologous Transplantation after a Rituximab/Ibrutinib/Ara-c containing iNduction in Generalized mantle cell Lymphoma – a randomized Europea … Ended

2024-511235-10-00 5 2016-07-25 Generalized mantle cell Lymphoma

Showing 73–83 of 83 trials